← The Wire
GANXNasdaq
Gain Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1819411
Develops novel small molecule therapeutics for CNS, LSDs, metabolic, and oncology diseases using its Magellan™ platform
$72M
Market cap
$1.98
Last close
+13.1%
1D
+7.0%
5D
12.5M
Volume
Price · last 39 sessions+4.2%
May 4L $1.59 · H $2.02Jun 29
106
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AApr 28, 2026DEFA14ADEFA14AApr 29, 2025DEFA14ADEFA14AApr 26, 2024DEFA14ADEFA14AApr 28, 2023
Similar companies
Comparable business profile · signals at a glance